Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Safety of TZP-101 (Ulimorelin) in Post-Operative Bowel Resection
NCT01710982Phase 3Completed
- Sponsor
- Norgine
- Start
- Feb 2012
- Primary completion
- Apr 2012
- Modality
- Small Molecules, Cyclic Peptides
01
Overview
A Phase 3 trial of ulimorelin in postoperative ileus (POI), sponsored by Norgine. Started Feb 2012; status: completed.
02
Drugs
ulimorelin
03
Conditions
postoperative ileus (POI)
Beyond the preview
Go deeper on NCT01710982.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01710982.